Six samples of Favipiravir brands found spurious

Nagpur | Wednesday | 2nd June, 2021

Summary:

FDA raided the premises of three depots where the stocks of Favipiravir brands - Favimax 400 and Favimax 200 - were stored. According to a source from FDA “As per a confidential report the two brands Favimax 400 (Favipiravir Tablets 400) Favimax 200 (Favipiravir Tablets 200) are being sold on-line to the customers across the country. The officials found stock of Favipiravir tablets Favimax 400 mg Favimax 200 mg and Hydroxy Chloro Quine Tablets M HCQ 400 Tablets manufactured by M/s Max Relief Healthcare Village Anji Solan Himachal Pradesh-1730212 and marketed by Covalent Healthcare Kolkata. The Government public analyst has given the report on May 31 and all six samples of Favimax tablets were declared as spurious. All are also requested to verify and make Favipiravir tablets of other manufacturers available..